Braeburn Pharmaceuticals' Mezzanine Round

Braeburn Pharmaceuticals raised a round of funding on January 11, 2018.

Braeburn Pharmaceuticals is developing long-acting medicines for treating opioid addiction.…

Articles about Braeburn Pharmaceuticals' Mezzanine Round: